6Definitions

#### 6 Definitions > Note 1: A number of expressions used in this instrument are defined in the Act, including the following: (a) hospital; (b) public hospital. > Note 2: Under subsection 4(1A) of the Act, a word or phrase used in the Act that is defined for the purposes of the Health Insurance Act 1973 has the meaning that it would have if used in that Act. Expressions used in this instrument that take their meaning from that Act include the following: (a) medical practitioner; (b) private hospital; (c) specialist. In this instrument: > Act means the National Health Act 1953. > approved ex‑manufacturer price of a listed brand of a pharmaceutical item has the same meaning as in Part VII of the Act. > approved hospital authority has the same meaning as in Part VII of the Act. > botulinum toxin pharmaceutical benefit means a pharmaceutical benefit mentioned in Schedule 1. > CTG registered patient means a patient registered under subsection 10(2) of the CTG Special Arrangement. > CTG Special Arrangement means the National Health (Closing the Gap – PBS Co‑payment Program) Special Arrangement 2016. > dispensed price: (a) for the special arrangement supply of a botulinum toxin pharmaceutical benefit by an approved hospital authority for a public hospital—has the meaning given by section 13; and (b) for the special arrangement supply of a botulinum toxin pharmaceutical benefit by an approved hospital authority for a private hospital—has the meaning given by section 15. > eligible medical practitioner: see section 7. > eligible patient: see section 8. > listed brand of a pharmaceutical item has the same meaning as in Part VII of the Act. > Listing Instrument means the National Health (Listing of Pharmaceutical Benefits) Instrument 2024. > maximum quantity: see subsection 16(2). > pack quantity of a listed brand of a pharmaceutical item has the same meaning as in Part VII of the Act. > PBS prescriber has the same meaning as in Part VII of the Act. > pharmaceutical benefit has the same meaning as in Part VII of the Act. > pharmaceutical item has the same meaning as in Part VII of the Act. > proportional ex‑manufacturer price of a listed brand of a pharmaceutical item has the same meaning as in Part VII of the Act. > ready‑prepared dispensing fee has the same meaning as in the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020. > ready‑prepared pharmaceutical benefit has the same meaning as in the Listing Instrument. > special arrangement supply: see subsection 9(1).